Circulation

NOVEMBER 11, 2024

Background:Severe COVID-19 infection has been associated with acute respiratory distress syndrome (ARDS) and right ventricular (RV) dysfunction. A retrospective chart review was performed on 41 patients with COVID-19 on ECMO between March and October 2020.

COVID-19 40

COVID-19 Laboratory Biomarkers Echocardiogram 40

Circulation

NOVEMBER 11, 2024

Background:It is still not well understood whether cardiac injury observed during acute COVID-19 infection extends after recovery from the initial viral infection. Patients were included if they had: 1) acute COVID-19 infection confirmed by RT-PCR and 2) a transthoracic echocardiogram (TTE) performed during their hospitalization.

COVID-19 40

COVID-19 Echocardiogram Hospital Circulation 40

Heart BMJ

NOVEMBER 27, 2023

We examined incidental non-COVID-19 cardiovascular pathology in college athletes undergoing postinfection return-to-play screening. Athletes with an ECG and transthoracic echocardiogram (TTE) and no pre-existing conditions were included.

COVID-19 52

COVID-19 Sudden Cardiac Death Aortic Atrial Fibrillation 52

DAIC

AUGUST 29, 2024

Echocardiograms using the robotic arm resulted in the same diagnosis as conventional in-person echocardiography in 98% of cases (papillary muscle level obstruction was missed in one case). tim.hodson Thu, 08/29/2024 - 11:39 Aug. 28, 2024 — New research presented at this year’s ESC Congress 2024 in London, UK (Aug. 30 – Sept.

Echocardiogram 52

Echocardiogram Bicuspid/Mitral Aortic valve Outpatient 52

Open Heart

MAY 9, 2022

Objective To identify the most common transthoracic echocardiogram (TTE) parameters in patients hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) and their association with myocardial injury and outcomes. Moreover, COVID-19-induced myocarditis remains extremely rare.

COVID-19 52

COVID-19 Inpatient Risk Factors Echocardiogram 52

Open Heart

APRIL 20, 2022

Objective To assess the feasibility, efficacy and safety of performing exercise stress echocardiography (ESE) for the assessment of myocardial ischaemia during the COVID-19 pandemic. Of the 17 healthcare professionals performing ESE, none contracted COVID-19 during this period. SE service performance increased to 96.8%

COVID-19 52

COVID-19 Exercise Coronary Artery Disease Echocardiogram 52

SoftCath

MAY 22, 2021

The existence of the Covid-19 pandemic has shaken the lives of people around the world and is continuing to do so. Primarily, physicians were suspecting Covid-19 to be a respiratory disorder. Now let us move forward and study some other crucial impacts of Covid-19 on cardiology departments.

COVID-19 52

COVID-19 Blood Clot Technology Cardiovascular Disease 52